Jason Haas

Entity
Individual
Business address
C/O Syros Pharmaceuticals, Inc., 35 Cambridgepark Drive, 02140 Cambridge, MA
Signature Ownership
By: /s/ Andrew Reardon, Attorney-in-Fact For: Jason Haas
All SEC filings
View on sec.gov
Get insider transactions for this reporting owner
Jason Haas has filed 18 SEC EDGAR filings since 10/13/2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing PRIMARY DOCUMENT Jun 10, 2025 Jun 6, 2025 001-33093
4 Open Document Open Filing 4 Nov 20, 2024 Nov 18, 2024 001-37813
144 Open Document Open Filing Nov 18, 2024
144 Open Document Open Filing Nov 18, 2024
4 Open Document Open Filing 4 Nov 4, 2024 Oct 31, 2024 001-37813
4 Open Document Open Filing 4 Sep 12, 2024 Sep 10, 2024 001-37813
4 Open Document Open Filing PRIMARY DOCUMENT Jun 18, 2024 Jun 14, 2024 001-33093
4 Open Document Open Filing 4 Apr 2, 2024 Mar 31, 2024 001-37813
4 Open Document Open Filing FORM 4 SUBMISSION Nov 2, 2023 Oct 31, 2023 001-37813
4 Open Document Open Filing PRIMARY DOCUMENT Jun 13, 2023 Jun 9, 2023 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Apr 4, 2023 Mar 31, 2023 001-37813
4 Open Document Open Filing FORM 4 SUBMISSION Feb 21, 2023 Feb 16, 2023 001-37813
4 Open Document Open Filing FORM 4 SUBMISSION Oct 11, 2022 Oct 6, 2022 001-37813
4 Open Document Open Filing PRIMARY DOCUMENT Jun 30, 2022 Jun 29, 2022 001-33093
3 Open Document Open Filing PRIMARY DOCUMENT Jun 29, 2022 Jun 29, 2022 001-33093
4 Open Document Open Filing FORM 4 SUBMISSION Feb 17, 2022 Feb 15, 2022 001-37813
4 Open Document Open Filing FORM 4 SUBMISSION Oct 13, 2021 Oct 12, 2021 001-37813
3 Open Document Open Filing FORM 3 SUBMISSION Oct 13, 2021 Oct 12, 2021 001-37813